Impact of intra-operative fluid and noradrenaline administration on early postoperative renal function after cystectomy and urinary diversion: A retrospective observational cohort study.

Furrer, Marc; Schneider, Marc Philipp; Löffel, Lukas M.; Burkhard, Fiona C.; Wüthrich, Patrick Yves (2018). Impact of intra-operative fluid and noradrenaline administration on early postoperative renal function after cystectomy and urinary diversion: A retrospective observational cohort study. European journal of anaesthesiology, 35(9), pp. 641-649. Lippincott Williams & Wilkins 10.1097/EJA.0000000000000808

[img] Text
Bu_Impact of intra-operative fluid_Eur J Anaesthesiol_2018.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (870kB) | Request a copy

BACKGROUND

The use of noradrenaline to enable a restrictive approach to intra-operative fluid therapy to avoid salt and water overload has gained increasing acceptance. However, concerns have been raised about the impact of this approach on renal function.

OBJECTIVES

To identify risk factors for acute kidney injury (AKI) in patients undergoing cystectomy with urinary diversion and determine whether administration of noradrenaline and intra-operative hydration regimens affect early postoperative renal function.

DESIGN

Retrospective observational cohort study.

SETTING

University hospital, from 2007 to 2016.

PATIENTS

A total of 769 consecutive patients scheduled for cystectomy and urinary diversion. Those with incomplete data and having pre-operative haemodialysis were excluded.

MAIN OUTCOME MEASURES

AKI was defined as a serum creatinine increase of more than 50% over 72 postoperative hours. Multiple logistic regression analysis was performed to model the association between risk factors and AKI.

RESULTS

Postoperative AKI was diagnosed in 86/769 patients (11.1%). Independent predictors for AKI were the amount of crystalloid administered (odds ratio (OR) 0.79 [95% confidence interval (CI), 0.68 to 0.91], P = 0.002), antihypertensive medication (OR 2.07 [95% CI, 1.25 to 3.43], P = 0.005), pre-operative haemoglobin value (OR 1.02 [95% CI, 1.01 to 1.03], P = 0.010), duration of surgery (OR 1.01 [95% CI, 1.00 to 1.01], P = 0.002), age (OR 1.32 [95% CI, 1.44 to 1.79], P = 0.002) but not the administration of noradrenaline (OR 1.09 [95% CI, 0.94 to 1.21], P = 0.097). Postoperative AKI was associated with longer hospital stay (18 [15 to 22] vs. 16 [15 to 19] days; P = 0.035) and a higher 90-day major postoperative complication rate (41.9 vs. 27.5%; P = 0.002).

CONCLUSION

Noradrenaline administration did not increase the risk for AKI. A too restrictive approach to administration of crystalloids was associated with an increased risk for AKI, particularly in older patients, those receiving antihypertensive medication, and those whose surgery was prolonged. As AKI was associated with longer hospital stay and increased postoperative morbidity, these observations should be taken into account to improve outcome when addressing peri-operative fluid management.

TRIAL REGISTRATION

Not applicable.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology
04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy

UniBE Contributor:

Furrer, Marc, Schneider, Marc Philipp, Löffel, Lukas, Burkhard, Fiona Christine, Wüthrich, Patrick Yves

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0265-0215

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Laetitia Hayoz

Date Deposited:

04 Jul 2018 15:47

Last Modified:

02 Mar 2023 23:30

Publisher DOI:

10.1097/EJA.0000000000000808

PubMed ID:

29652680

BORIS DOI:

10.7892/boris.118238

URI:

https://boris.unibe.ch/id/eprint/118238

Actions (login required)

Edit item Edit item
Provide Feedback